These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2358844)

  • 1. Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.
    Bowles AP; Pantazis CG; Wansley W; Allen MB
    J Neurooncol; 1990 Apr; 8(2):103-12. PubMed ID: 2358844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of verapamil to enhance the antiproliferative activity of BCNU in human glioma cells: an in vitro and in vivo study.
    Bowles AP; Pantazis CG; Wansley W
    J Neurosurg; 1990 Aug; 73(2):248-53. PubMed ID: 2366081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.
    Bradford R; Darling JL; Sier N; Thomas DG
    J Neurooncol; 1990 Oct; 9(2):105-14. PubMed ID: 2262797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
    Tonn JC; Schönmayr R; Kraemer HP
    J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.
    Van Meter TE; Broaddus WC; Cash D; Fillmore H
    Cancer; 2006 Nov; 107(10):2446-54. PubMed ID: 17041888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the fluorescent probe viability assay.
    Massaro EJ; Elstein KH; Zucker RM; Bair KW
    Mol Toxicol; 1989; 2(4):271-84. PubMed ID: 2490980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified tritiated thymidine incorporation assay for chemosensitivity testing of human tumors.
    Wada T; Akiyoshi T; Nakamura Y
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1421-4. PubMed ID: 3181266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorometric rapid microassay to identify anti-proliferative compounds for human melanoma cells in vitro.
    Zouboulis CC; Garbe C; Krasagakis K; Krüger S; Orfanos CE
    Melanoma Res; 1991; 1(2):91-5. PubMed ID: 1726673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
    Gerçel-Taylor C; Ackermann MA; Taylor DD
    Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An isotope agarose assay for rapid testing of the sensitivity of glioma biopsies to chemotherapeutic drugs and biological response modifiers. Effects of BCNU, vincristine, lymphokines and the recombinant agents interferon alpha 2c, interferon gamma and tumour necrosis factor.
    Unsgaard G; Helseth E; Vik R; Dalen A
    Acta Neurochir (Wien); 1988; 91(1-2):60-6. PubMed ID: 2455960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
    Kaaijk P; Troost D; de Boer OJ; Van Amstel P; Bakker PJ; Leenstra S; Bosch DA
    Br J Cancer; 1996 Jul; 74(2):187-93. PubMed ID: 8688320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin expression in the untreated and SarCNU-exposed human glioma cell line, SK-MG-1.
    Schipper HM; Skalski V; Panasci LC; Wang E
    Cancer Chemother Pharmacol; 1990; 26(5):383-6. PubMed ID: 2208582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
    Fischel JL; Formento P; Etienne MC; Gioanni J; Frenay M; Deloffre P; Bizzari JP; Milano G
    Cancer Chemother Pharmacol; 1990; 25(5):337-41. PubMed ID: 2306793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks.
    El-Deredy W; Ashmore SM; Branston NM; Darling JL; Williams SR; Thomas DG
    Cancer Res; 1997 Oct; 57(19):4196-9. PubMed ID: 9331074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
    Haselsberger K; Peterson DC; Thomas DG; Darling JL
    Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro drug sensitivity testing in human gliomas.
    Kimmel DW; Shapiro JR; Shapiro WR
    J Neurosurg; 1987 Feb; 66(2):161-71. PubMed ID: 3543252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative fluorescent microassay for identification of antiproliferative compounds.
    Saiki I; Bucana CD; Tsao JY; Fidler IJ
    J Natl Cancer Inst; 1986 Dec; 77(6):1235-40. PubMed ID: 2432304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro cloning assays for drug sensitivity testing of human brain tumours.
    Berens ME; Giblin JR; Dougherty DV; Hoifodt HK; Tveit K; Rosenblum ML
    Br J Neurosurg; 1988; 2(2):227-34. PubMed ID: 3267306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.